非洲主导的艾滋病疫苗试验在南非启动

Core Viewpoint - The BRILLIANT 011 trial, led by the BRILLIANT Alliance, has been launched in Cape Town to develop an HIV vaccine targeting specific virus strains prevalent in Southern Africa [1] Group 1: Trial Details - The BRILLIANT 011 trial is implemented by the South African Medical Research Council (SAMRC) [1] - The trial aims to combat specific strains of the virus that are widespread in Southern Africa [1] - The initiative has already enrolled its first participant and is set to officially commence in 2024 [1] Group 2: Research Collaboration - The project brings together top researchers from multiple African countries, including South Africa, Nigeria, Uganda, Kenya, Tanzania, Zimbabwe, Zambia, and Mozambique [1]